Playback speed
×
Share post
Share post at current time
0:00
/
0:00
3

Could Nutraceuticals benefit long Covid patients? - Joachim Gerlach (Vedicinals 9)

3

Watch full Long Covid Solutions Congress March 2022 here >

Joachim Gerlach is a German entrepreneur and expert in research and development. He has experience in financing and coordinating multiple projects, including sustainable organic agriculture, reforestation and agroforestry projects, restoring micronutrition levels in plants, animals and humans, as well as the development and production of targeted nutraceuticals.

Mr Gerlach is the Founder of GREEN INDUSTRY GROUP GmbH (Germany-Costa Rica) and VITALIS FOUNDATION SPAIN (Canary Islands), and Co-founder of VEDICINALS INDIA PVT LTD, a biotech company that recently developed a novel nutraceutical protocol to support patients with acute- and Long-Covid conditions.

The resulting product VEDICINALS 9 has successfully completed extensive preclinical and clinical trials.

Thanks for reading Long Covid Analysed! Subscribe for free to receive new posts and support my work.

3 Comments
Long Covid Analysed
Long Covid Analysed
Authors
Dr Philip McMillan